The Latest Breaking News from VistaGen rapeutics

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.

Benzinga · Aug 22, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

 

Benzinga · Aug 11, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022

Upgrades

Benzinga · Jul 26, 2022

Looking Into VistaGen Therapeutics's Return On Capital Employed

Benzinga Pro data, VistaGen Therapeutics (NASDAQ:VTGN) reported Q4 sales of $38.90 thousand. Earnings fell to a loss of $16.69 million, resulting in a 58.41% decrease from last quarter.

Benzinga · Jun 28, 2022

Earnings Preview For VistaGen Therapeutics

VistaGen Therapeutics (NASDAQ:VTGN) is set to give its latest quarterly earnings report on Thursday, 2022-06-23. Here's what investors need to know before the announcement. Analysts estimate that VistaGen Therapeutics will report an earnings per share (EPS) of $-0.06.

Benzinga · Jun 22, 2022

VistaGen Therapeutics Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q3, VistaGen Therapeutics's (NASDAQ:VTGN) reported sales totaled $357.90 thousand. Despite a 17.66% increase in earnings, the company posted a loss of $10.54 million.

Benzinga · Feb 14, 2022